{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-019788","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.388533+00:00","generated_at":"2026-05-15T00:41:18.337879+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Glucotrack publishes peer-reviewed study showing CBGM accuracy MARD 6.8% over 240 days in ovine model","bullets":["Study in Journal of Diabetes Research shows weighted average MARD of 6.8% across 79 IV glucose tolerance tests in ovine model.","34 devices implanted in 17 sheep; no device-related adverse events observed over up to 240 days.","Results support path to IDE submission with FDA for further clinical development toward commercialization.","Prior first-in-human study demonstrated MARD of 7.7% with 99% data capture and no serious adverse events."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-019788","json":"https://secwatch.observer/filing/0001493152-26-019788.json","markdown":"https://secwatch.observer/filing/0001493152-26-019788.md","text":"https://secwatch.observer/filing/0001493152-26-019788.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226019788/0001493152-26-019788-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226019788/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:41:18.337879+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}